CV Sciences (CVSI) Revenue (2013 - 2026)

CV Sciences has disclosed Revenue across 14 years of filings, most recently posting $3.2 million for Q1 2026.

• Revenue for Q1 2026 came in at $3.2 million, down 11.4% year-over-year; the trailing twelve-month figure through Mar 2026 was $13.4 million (down 12.61% YoY), and the FY2025 annual result was $13.8 million, down 12.2% from the prior year.
• Revenue came in at $3.2 million for Q1 2026 at CV Sciences, down from $3.3 million in the prior quarter.
• In the past five years, Revenue ranged from a high of $4.4 million in Q1 2022 to a low of $3.2 million in Q1 2026.
• The 5-year median for Revenue is $3.9 million (2022), against an average of $3.8 million.
• Across the five-year window, Revenue retreated 26.55% in 2022 and advanced 9.01% in 2023, its largest moves.
• CV Sciences' Revenue stood at $3.9 million in 2022, then retreated by 1.76% to $3.8 million in 2023, then gained by 2.18% to $3.9 million in 2024, then retreated by 14.86% to $3.3 million in 2025, then declined by 3.39% to $3.2 million in 2026.
• The last three Revenue figures came in at $3.2 million (Q1 2026), $3.3 million (Q4 2025), and $3.3 million (Q3 2025), per Business Quant data.